Sorafenib enhances pemetrexed cytotoxicity through an autophagy-dependent mechanism in cancer cells.
Bareford MD, Park MA, Yacoub A, Hamed HA, Tang Y, Cruickshanks N, Eulitt P, Hubbard N, Tye G, Burow ME, Fisher PB, Moran RG, Nephew KP, Grant S, Dent P.
Bareford MD, et al. Among authors: cruickshanks n.
Cancer Res. 2011 Jul 15;71(14):4955-67. doi: 10.1158/0008-5472.CAN-11-0898. Epub 2011 May 27.
Cancer Res. 2011.
PMID: 21622715
Free PMC article.